Corrigendum to "Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A" [Contraception 2016;93:498-506].
UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland.
Patrick
P
Rowe
UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland.
Tim
T
Farley
UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland.
Alexandre
A
Peregoudov
Medical Statistics Department, London School of Hygiene and Tropical Medicine, London, UK.
Gilda
G
Piaggio
UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland.
Simone
S
Boccard
Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Sihem
S
Landoulsi
Instituto Chileno de Medicina Reproductiva (ICMER), Santiago, Chile. Electronic address: olav.meirik@gmx.com.
Olav
O
Meirik